Are clinical impact of immune microenvironment in stage I lung adenocarcinoma : tumor interleukin-12 receptor β2 ( IL-12Rβ2 ) , IL-7R , and stromal FoxP3/CD3 ratio independent predictors of recurrence?
Our investigation confirms the biologic and prognostic significance of the tumor immune microenvironment for patients with stage I lung ADC and provides support for its use to stratify clinical outcome and immunotherapeutic interventions.
Met is an important promotor of DMs formation.